The Tulane University School of Medicine is located in New Orleans, Louisiana, United States and is a part of Tulane University. The school is located in the Medical District of the New Orleans Central Business District.

During the past decade, Tulane University School of Medicine conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 26 clinical trials were completed, i.e. on average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 13 clinical trials were completed. i.e. 48.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tulane University School of Medicine" #1 sponsor was "SWOG Cancer Research Network" with 51 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 41 trials sponsored, "Radiation Therapy Oncology Group" with 33 trials sponsored, "Children's Oncology Group" with 19 trials sponsored and "Eastern Cooperative Oncology Group" with 19 trials sponsored. Other sponsors include 102 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane University School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 125 trials as a collaborator, "SWOG Cancer Research Network" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 7 trials as a collaborator and "Bristol-Myers Squibb" with 6 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Tulane University School of Medicine" are "HIV Infections" (61 trials), "Leukemia" (18 trials), "Lung Cancer" (16 trials), "Lymphoma" (13 trials) and "Head and Neck Cancer" (11 trials). Many other conditions were trialed in "Tulane University School of Medicine" in a lesser frequency.

Most popular intervention types in "Tulane University School of Medicine" are "Drug" (214 trials), "Radiation" (51 trials), "Biological" (46 trials), "Procedure" (34 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (45 trials), "Zidovudine" (24 trials), "cyclophosphamide" (23 trials), "cisplatin" (22 trials) and "etoposide" (22 trials). Other intervention names were less common.

The vast majority of trials in "Tulane University School of Medicine" are 226 trials for "All" genders, 17 trials for "Male" genders and 14 trials for "Female" genders.

Currently, there are 20 active trials in "Tulane University School of Medicine". 1 are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 198 completed trials in Tulane University School of Medicine, undefined suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Tulane University School of Medicine, 31 "Phase 1" clinical trials were conducted, 117 "Phase 2" clinical trials and 88 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 18 trials that are defined as “Not Applicable".